Dimethyltryptamine molecule:

Image from PubChem

DMT Clinical Trials


A Phase 2 Clinical Trial of GH001 in Patients with Bipolar II Disorder and a Current Major Depressive Episode


To see complete record on www.clinicaltrialsregister.eu, please visit this link

Id: 2021-006861-39

Organisation Name: GH Research Ireland Limited

Start Date: 2022-03-31

Completion Date: Ongoing

Brief Summary: To determine the onset and 7-day durability of anti-depressive effects of a single-day individualized dosing regimen of 6 mg, 12 mg and 18 mg of GH001 in patients with bipolar II disorder and a current major depressive episode.

Country: Ireland



Total execution time in seconds: 0.091276168823242